Fig. 10From: Dose-dependent benefits of iron-magnetic nanoparticle-coated human umbilical-derived mesenchymal stem cell treatment in rat intracranial hemorrhage modelIllustrating the Schematically proposed mechanism of hUC-MSCs therapy for protecting the brain against ICH damage. ICH = intracranial hemorrhage; hUC-MSCs = human umbilical cord-derived mesenchymal stem cellsBack to article page